Monday , April 24 2017
Home / Treatments and Medicines / Pioneering Neuroprotective Results Achieved in Parkinson’s Disease Preclinical Studies

Pioneering Neuroprotective Results Achieved in Parkinson’s Disease Preclinical Studies

Pioneering Neuroprotective Results Achieved in Parkinson’s Disease Preclinical Studies
Allows immune system to repair brain damage; results reported in Journal of Neuroscience
A team of scientists at the University of Nebraska Medical Center (UNMC) and Longevity Biotech, Inc. demonstrated that neuroprotection could be attained in preclinical models by a novel drug candidate that changes immune responses. The results, published today in the Journal of Neuroscience, describe the prevention of nerve cell damage in a mouse model of Parkinson’s disease. Notably, the drug protected nerve cells that produce dopamine, which is the chemical responsible for agility and movement that is lost in human disease.
http://www.prnewswire.com/news-releases/pioneering-neuroprotective-results-achieved-in-parkinsons-disease-preclinical-studies-300193581.html

Check Also

Research reveals exercise slows progression of Parkinson’s

New research reveals how the exercise of any kind can dramatically improve the slowness, stiffness, …

Leave a Reply

Your email address will not be published. Required fields are marked *